Review



neonatal primary epidermal melanocytes hema  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC neonatal primary epidermal melanocytes hema
    The FER1L4 in melanoma cell lines and in TCGA patients: A) Expression levels in HEMn and <t>HEMa</t> <t>melanocytes</t> and melanoma cell lines depending on the cell type, cell line and BRAF status: BRAF WT (MEVO), BRAF V600E (SKMEL28, WM9 and A549) and BRAF V600D (WM115 and WM266) and B) Expression levels in melanoma patients from TCGA database depending on: primary or distant metastases samples and regional nodal metastases status and BRAF mutation status. Correlation of expression levels between BRAF and the FER1L4 in melanoma BRAF wild type (WT), BRAF mutated (MUT) and BRAF V600E (c. 1799T>A) subgroups; Graphs for metastasis status were taken from UALCAN database, modified; T- test or One way ANOVA with Kruskal-Wallis test, Spearman correlation test, p < 0.05 considered as significant; ns - no significant, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001
    Neonatal Primary Epidermal Melanocytes Hema, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 376 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/neonatal primary epidermal melanocytes hema/product/ATCC
    Average 99 stars, based on 376 article reviews
    neonatal primary epidermal melanocytes hema - by Bioz Stars, 2026-02
    99/100 stars

    Images

    1) Product Images from "Fer-1 like family member 4 pseudogene: novel potential diagnostic and prognostic biomarker for cutaneous melanoma"

    Article Title: Fer-1 like family member 4 pseudogene: novel potential diagnostic and prognostic biomarker for cutaneous melanoma

    Journal: EXCLI Journal

    doi: 10.17179/excli2024-7719

    The FER1L4 in melanoma cell lines and in TCGA patients: A) Expression levels in HEMn and HEMa melanocytes and melanoma cell lines depending on the cell type, cell line and BRAF status: BRAF WT (MEVO), BRAF V600E (SKMEL28, WM9 and A549) and BRAF V600D (WM115 and WM266) and B) Expression levels in melanoma patients from TCGA database depending on: primary or distant metastases samples and regional nodal metastases status and BRAF mutation status. Correlation of expression levels between BRAF and the FER1L4 in melanoma BRAF wild type (WT), BRAF mutated (MUT) and BRAF V600E (c. 1799T>A) subgroups; Graphs for metastasis status were taken from UALCAN database, modified; T- test or One way ANOVA with Kruskal-Wallis test, Spearman correlation test, p < 0.05 considered as significant; ns - no significant, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001
    Figure Legend Snippet: The FER1L4 in melanoma cell lines and in TCGA patients: A) Expression levels in HEMn and HEMa melanocytes and melanoma cell lines depending on the cell type, cell line and BRAF status: BRAF WT (MEVO), BRAF V600E (SKMEL28, WM9 and A549) and BRAF V600D (WM115 and WM266) and B) Expression levels in melanoma patients from TCGA database depending on: primary or distant metastases samples and regional nodal metastases status and BRAF mutation status. Correlation of expression levels between BRAF and the FER1L4 in melanoma BRAF wild type (WT), BRAF mutated (MUT) and BRAF V600E (c. 1799T>A) subgroups; Graphs for metastasis status were taken from UALCAN database, modified; T- test or One way ANOVA with Kruskal-Wallis test, Spearman correlation test, p < 0.05 considered as significant; ns - no significant, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001

    Techniques Used: Expressing, Mutagenesis, Modification



    Similar Products

    neonatal primary epidermal melanocytes hema  (ATCC)
    99
    ATCC neonatal primary epidermal melanocytes hema
    The FER1L4 in melanoma cell lines and in TCGA patients: A) Expression levels in HEMn and <t>HEMa</t> <t>melanocytes</t> and melanoma cell lines depending on the cell type, cell line and BRAF status: BRAF WT (MEVO), BRAF V600E (SKMEL28, WM9 and A549) and BRAF V600D (WM115 and WM266) and B) Expression levels in melanoma patients from TCGA database depending on: primary or distant metastases samples and regional nodal metastases status and BRAF mutation status. Correlation of expression levels between BRAF and the FER1L4 in melanoma BRAF wild type (WT), BRAF mutated (MUT) and BRAF V600E (c. 1799T>A) subgroups; Graphs for metastasis status were taken from UALCAN database, modified; T- test or One way ANOVA with Kruskal-Wallis test, Spearman correlation test, p < 0.05 considered as significant; ns - no significant, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001
    Neonatal Primary Epidermal Melanocytes Hema, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/neonatal primary epidermal melanocytes hema/product/ATCC
    Average 99 stars, based on 1 article reviews
    neonatal primary epidermal melanocytes hema - by Bioz Stars, 2026-02
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    The FER1L4 in melanoma cell lines and in TCGA patients: A) Expression levels in HEMn and HEMa melanocytes and melanoma cell lines depending on the cell type, cell line and BRAF status: BRAF WT (MEVO), BRAF V600E (SKMEL28, WM9 and A549) and BRAF V600D (WM115 and WM266) and B) Expression levels in melanoma patients from TCGA database depending on: primary or distant metastases samples and regional nodal metastases status and BRAF mutation status. Correlation of expression levels between BRAF and the FER1L4 in melanoma BRAF wild type (WT), BRAF mutated (MUT) and BRAF V600E (c. 1799T>A) subgroups; Graphs for metastasis status were taken from UALCAN database, modified; T- test or One way ANOVA with Kruskal-Wallis test, Spearman correlation test, p < 0.05 considered as significant; ns - no significant, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001

    Journal: EXCLI Journal

    Article Title: Fer-1 like family member 4 pseudogene: novel potential diagnostic and prognostic biomarker for cutaneous melanoma

    doi: 10.17179/excli2024-7719

    Figure Lengend Snippet: The FER1L4 in melanoma cell lines and in TCGA patients: A) Expression levels in HEMn and HEMa melanocytes and melanoma cell lines depending on the cell type, cell line and BRAF status: BRAF WT (MEVO), BRAF V600E (SKMEL28, WM9 and A549) and BRAF V600D (WM115 and WM266) and B) Expression levels in melanoma patients from TCGA database depending on: primary or distant metastases samples and regional nodal metastases status and BRAF mutation status. Correlation of expression levels between BRAF and the FER1L4 in melanoma BRAF wild type (WT), BRAF mutated (MUT) and BRAF V600E (c. 1799T>A) subgroups; Graphs for metastasis status were taken from UALCAN database, modified; T- test or One way ANOVA with Kruskal-Wallis test, Spearman correlation test, p < 0.05 considered as significant; ns - no significant, * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001

    Article Snippet: Human adult and neonatal primary epidermal melanocytes HEMa (ATCC® PCS-200-013) andHEMn (ATCC® PCS-200-012), respectively, and human melanoma cell lines MEWO, SKMEL28, WM115, WM266, WM9, and A549 were used for the study.

    Techniques: Expressing, Mutagenesis, Modification